Cargando…
Downregulation of vimentin expression increased drug resistance in ovarian cancer cells
Cisplatin and other platinum-based drugs have been widely used in the treatment of ovarian cancer, but most patients acquire the drug resistance that greatly compromises the efficacy of drugs. Understanding the mechanism of drug resistance is important for finding new therapeutic approaches. In the...
Autores principales: | Huo, Yi, Zheng, Zhiguo, Chen, Yuling, Wang, Qingtao, Zhang, Zhenyu, Deng, Haiteng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216767/ https://www.ncbi.nlm.nih.gov/pubmed/27322682 http://dx.doi.org/10.18632/oncotarget.9970 |
Ejemplares similares
-
ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair
por: Huo, Yi, et al.
Publicado: (2017) -
Proteomic Analysis of Drug-Resistant Mycobacteria: Co-Evolution of Copper and INH Resistance
por: Chen, Yuling, et al.
Publicado: (2015) -
Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics
por: Qu, Hong, et al.
Publicado: (2016) -
Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma
por: Tang, Haiping, et al.
Publicado: (2016) -
Comparative proteomic analysis identifies biomarkers for renal aging
por: Yi, Meiqi, et al.
Publicado: (2020)